339 related articles for article (PubMed ID: 32747155)
1. Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico.
Hernández-Galdamez DR; González-Block MÁ; Romo-Dueñas DK; Lima-Morales R; Hernández-Vicente IA; Lumbreras-Guzmán M; Méndez-Hernández P
Arch Med Res; 2020 Oct; 51(7):683-689. PubMed ID: 32747155
[TBL] [Abstract][Full Text] [Related]
2. Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.
Bello-Chavolla OY; Bahena-López JP; Antonio-Villa NE; Vargas-Vázquez A; González-Díaz A; Márquez-Salinas A; Fermín-Martínez CA; Naveja JJ; Aguilar-Salinas CA
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32474598
[TBL] [Abstract][Full Text] [Related]
3. Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of Mexico.
Martos-Benítez FD; Soler-Morejón CD; García-Del Barco D
Intern Emerg Med; 2021 Sep; 16(6):1507-1517. PubMed ID: 33411264
[TBL] [Abstract][Full Text] [Related]
4. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
5. Insights from Chilean NCDs Hospitalization Data during COVID-19.
Vásquez-Gómez JA; Saracini C
Medicina (Kaunas); 2024 May; 60(5):. PubMed ID: 38792953
[TBL] [Abstract][Full Text] [Related]
6. The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa.
Mnguni AT; Schietekat D; Ebrahim N; Sonday N; Boliter N; Schrueder N; Gabriels S; Cois A; Tamuzi JL; Tembo Y; Davies MA; English R; Nyasulu PS
PLoS One; 2023; 18(10):e0277995. PubMed ID: 37796879
[TBL] [Abstract][Full Text] [Related]
7. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for SARS-CoV-2 Infection, Pneumonia, Intubation, and Death in Northeast Mexico.
Cordero-Franco HF; De La Garza-Salinas LH; Gomez-Garcia S; Moreno-Cuevas JE; Vargas-Villarreal J; González-Salazar F
Front Public Health; 2021; 9():645739. PubMed ID: 34291023
[TBL] [Abstract][Full Text] [Related]
9. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico.
Peña JE; Rascón-Pacheco RA; Ascencio-Montiel IJ; González-Figueroa E; Fernández-Gárate JE; Medina-Gómez OS; Borja-Bustamante P; Santillán-Oropeza JA; Borja-Aburto VH
Arch Med Res; 2021 May; 52(4):443-449. PubMed ID: 33380361
[TBL] [Abstract][Full Text] [Related]
10. Pregnant women with SARS-CoV-2 infection are at higher risk of death and pneumonia: propensity score matched analysis of a nationwide prospective cohort (COV19Mx).
Martinez-Portilla RJ; Sotiriadis A; Chatzakis C; Torres-Torres J; Espino Y Sosa S; Sandoval-Mandujano K; Castro-Bernabe DA; Medina-Jimenez V; Monarrez-Martin JC; Figueras F; Poon LC
Ultrasound Obstet Gynecol; 2021 Feb; 57(2):224-231. PubMed ID: 33320401
[TBL] [Abstract][Full Text] [Related]
11. Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico.
Gutierrez JP; Bertozzi SM
PLoS One; 2020; 15(10):e0240394. PubMed ID: 33031467
[TBL] [Abstract][Full Text] [Related]
12. Early estimation of the risk factors for hospitalization and mortality by COVID-19 in Mexico.
Carrillo-Vega MF; Salinas-Escudero G; García-Peña C; Gutiérrez-Robledo LM; Parra-Rodríguez L
PLoS One; 2020; 15(9):e0238905. PubMed ID: 32915872
[TBL] [Abstract][Full Text] [Related]
13. Obesity is a strong risk factor for short-term mortality and adverse outcomes in Mexican patients with COVID-19: a national observational study.
Vera-Zertuche JM; Mancilla-Galindo J; Tlalpa-Prisco M; Aguilar-Alonso P; Aguirre-García MM; Segura-Badilla O; Lazcano-Hernández M; Rocha-González HI; Navarro-Cruz AR; Kammar-García A; Vidal-Mayo JJ
Epidemiol Infect; 2021 Apr; 149():e109. PubMed ID: 33913410
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of hospitalization and death in Mexican children and adolescents with COVID-19 and comorbidities.
Méndez-Hernández P; Hernández-Galdamez DR; González-Block MA; Romo-Dueñas DK; Cahuantzi-Tamayo RM; Texis-Morales O; Medina-Urzúa JJ; Cerón-Meza R; Hernández-Vicente IA; Lumbreras-Guzmán M
Bol Med Hosp Infant Mex; 2023; 80(2):105-114. PubMed ID: 37155722
[TBL] [Abstract][Full Text] [Related]
15. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
16. Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages.
Sosa-Rubí SG; Seiglie JA; Chivardi C; Manne-Goehler J; Meigs JB; Wexler DJ; Wirtz VJ; Gómez-Dantés O; Serván-Mori E
Diabetes Care; 2021 Feb; 44(2):373-380. PubMed ID: 33208487
[TBL] [Abstract][Full Text] [Related]
17. The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing.
Palmer K; Monaco A; Kivipelto M; Onder G; Maggi S; Michel JP; Prieto R; Sykara G; Donde S
Aging Clin Exp Res; 2020 Jul; 32(7):1189-1194. PubMed ID: 32458356
[TBL] [Abstract][Full Text] [Related]
18. Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort.
Atkins JL; Masoli JAH; Delgado J; Pilling LC; Kuo CL; Kuchel GA; Melzer D
J Gerontol A Biol Sci Med Sci; 2020 Oct; 75(11):2224-2230. PubMed ID: 32687551
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for COVID-19 severe complications comparing three major epidemiological waves: An approach from primary health care in Mexico].
Oliva-Sánchez PF; Vadillo-Ortega F; Bojalil-Parra R; Martínez-Kobeh JP; Pérez-Pérez JR; Pérez-Avalos JL
Aten Primaria; 2022 Nov; 54(11):102469. PubMed ID: 36244180
[TBL] [Abstract][Full Text] [Related]
20. Comorbidities and laboratory parameters associated with SARS-CoV-2 infection severity in patients from the southeast of Mexico: a cross-sectional study.
De la Cruz-Cano E; Jiménez-González CDC; Díaz-Gandarilla JA; López-Victorio CJ; Escobar-Ramírez A; Uribe-López SA; Huerta-García E; Ayala-Sumuano JT; Morales-García V; Gútierrez-López L; González-Garrido JA
F1000Res; 2022; 11():10. PubMed ID: 35464048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
